{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:33:33Z","timestamp":1792607613961,"version":"4.5.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00134-025-08063-0","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T14:18:40Z","timestamp":1756736320000},"page":"1867-1885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Antibiotic therapy for severe bacterial infections"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6063-7383","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Timsit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lowell","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"de Montmollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Bracht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Conway-Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbet","family":"De Bus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick N. A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia R.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Artur","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garyphallia","family":"Poulakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Tabah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"8063_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M (2020) Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395:200\u2013211","journal-title":"Lancet"},{"key":"8063_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00134-022-06944-2","volume":"49","author":"A Tabah","year":"2023","unstructured":"Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT, Leone M, Conway Morris A, Bassetti M, Arvaniti K, Lipman J, Ferrer R, Qiu H, Paiva JA, Povoa P, De Bus L, De Waele J, Zand F, Gurjar M, Alsisi A, Abidi K, Bracht H, Hayashi Y, Jeon K, Elhadi M, Barbier F, Timsit JF, Eurobact-2 Study Group EEE, the ON (2023) Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med 49:178\u2013190","journal-title":"Intensive Care Med"},{"key":"8063_CR3","doi-asserted-by":"publisher","first-page":"e1066","DOI":"10.1097\/CCM.0000000000006606","volume":"53","author":"F Barbier","year":"2025","unstructured":"Barbier F, Buetti N, Dupuis C, Schwebel C, Azoulay E, Argaud L, Cohen Y, Hong Tuan Ha V, Gainnier M, Siami S, Forel JM, Adrie C, de Montmollin E, Reignier J, Ruckly S, Zahar JR, Timsit JF, OutcomeRea Study G (2025) Prognostic impact of early appropriate antimicrobial therapy in critically ill patients with nosocomial pneumonia due to gram-negative pathogens: a multicenter cohort study. Crit Care Med 53:e1066\u2013e1079","journal-title":"Crit Care Med"},{"key":"8063_CR4","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","volume":"323","author":"JL Vincent","year":"2020","unstructured":"Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, Finfer S, Pelosi P, Brazzi L, Aditianingsih D, Timsit JF, Du B, Wittebole X, Maca J, Kannan S, Gorordo-Delsol LA, De Waele JJ, Mehta Y, Bonten MJM, Khanna AK, Kollef M, Human M, Angus DC, Investigators EI (2020) Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323:1478\u20131487","journal-title":"JAMA"},{"key":"8063_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1164\/rccm.202112-2743OC","volume":"206","author":"A Li","year":"2022","unstructured":"Li A, Ling L, Qin H, Arabi YM, Myatra SN, Egi M, Kim JH, Mat Nor MB, Son DN, Fang WF, Wahyuprajitno B, Hashmi M, Faruq MO, Patjanasoontorn B, Al Bahrani MJ, Shrestha BR, Shrestha U, Nafees KMK, Sann KK, Palo JEM, Mendsaikhan N, Konkayev A, Detleuxay K, Chan YH, Du B, Divatia JV, Koh Y, Gomersall CD, Phua J (2022) Epidemiology, management, and outcomes of sepsis in ICUs among countries of differing national wealth across Asia. Am J Respir Crit Care Med 206:1107\u20131116","journal-title":"Am J Respir Crit Care Med"},{"key":"8063_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijid.2020.11.168","volume":"103","author":"Y Umemura","year":"2021","unstructured":"Umemura Y, Ogura H, Takuma K, Fujishima S, Abe T, Kushimoto S, Hifumi T, Hagiwara A, Shiraishi A, Otomo Y, Saitoh D, Mayumi T, Yamakawa K, Shiino Y, Nakada TA, Tarui T, Okamoto K, Kotani J, Sakamoto Y, Sasaki J, Shiraishi SI, Tsuruta R, Masuno T, Takeyama N, Yamashita N, Ikeda H, Ueyama M, Gando S, Japanese Association for Acute Medicine Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome S, Trauma Study G (2021) Current spectrum of causative pathogens in sepsis: a prospective nationwide cohort study in Japan. Int J Infect Dis 103:343\u2013351","journal-title":"Int J Infect Dis"},{"key":"8063_CR7","doi-asserted-by":"publisher","first-page":"e893","DOI":"10.1016\/S2542-5196(21)00280-1","volume":"5","author":"AJ Browne","year":"2021","unstructured":"Browne AJ, Chipeta MG, Haines-Woodhouse G, Kumaran EPA, Hamadani BHK, Zaraa S, Henry NJ, Deshpande A, Reiner RC Jr, Day NPJ, Lopez AD, Dunachie S, Moore CE, Stergachis A, Hay SI, Dolecek C (2021) Global antibiotic consumption and usage in humans, 2000\u201318: a spatial modelling study. Lancet Planet Health 5:e893\u2013e904","journal-title":"Lancet Planet Health"},{"key":"8063_CR8","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00134-019-05819-3","volume":"45","author":"S Blot","year":"2019","unstructured":"Blot S, Antonelli M, Arvaniti K, Blot K, Creagh-Brown B, de Lange D, De Waele J, Deschepper M, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovestky F, Maseda E, Montravers P, Mikstacki A, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D, Abdominal Sepsis Study group on behalf of the Trials Group of the European Society of Intensive Care M (2019) Epidemiology of intra-abdominal infection and sepsis in critically ill patients: \u201cAbSeS\u201d, a multinational observational cohort study and ESICM Trials Group Project. Intensive Care Med 45:1703\u20131717","journal-title":"Intensive Care Med"},{"key":"8063_CR9","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/CCM.0000000000005662","volume":"50","author":"A Gouel-Cheron","year":"2022","unstructured":"Gouel-Cheron A, Swihart BJ, Warner S, Mathew L, Strich JR, Mancera A, Follmann D, Kadri SS (2022) Epidemiology of ICU-onset bloodstream infection: prevalence, pathogens, and risk factors among 150,948 ICU patients at 85 U.S. Hospitals Crit Care Med 50:1725\u20131736","journal-title":"Hospitals Crit Care Med"},{"key":"8063_CR10","doi-asserted-by":"publisher","first-page":"106352","DOI":"10.1016\/j.ijantimicag.2021.106352","volume":"58","author":"PMM Perez-Crespo","year":"2021","unstructured":"Perez-Crespo PMM, Lanz-Garcia JF, Bravo-Ferrer J, Canton-Bulnes ML, Sousa Dominguez A, Goikoetxea Aguirre J, Reguera-Iglesias JM, Leon Jimenez E, Arminanzas Castillo C, Mantecon Vallejo MA, Marrodan Ciordia T, Fernandez Suarez J, Boix-Palop L, Cuquet Pedragosa J, Jover Saenz A, Sevilla Blanco J, Galan-Sanchez F, Natera Kindelan C, Del Arco Jimenez A, Bahamonde-Carrasco A, Smithson Amat A, Vinuesa Garcia D, Herrero Rodriguez C, Reche Molina IM, Perez Camacho I, Sanchez-Porto A, Guzman Garcia M, Becerril Carral B, Merino de Lucas E, Lopez-Hernandez I, Rodriguez-Bano J, Lopez-Cortes LE (2021) Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study). Int J Antimicrob Agents 58:106352","journal-title":"Int J Antimicrob Agents"},{"key":"8063_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1378\/chest.10-1715","volume":"139","author":"J Valles","year":"2011","unstructured":"Valles J, Alvarez-Lerma F, Palomar M, Blanco A, Escoresca A, Armestar F, Sirvent JM, Balasini C, Zaragoza R, Marin M, Study Group of Infectious Diseases of the Spanish Society of Critical Care M (2011) Health-care-associated bloodstream infections at admission to the ICU. Chest 139:810\u2013815","journal-title":"Chest"},{"key":"8063_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cid\/ciz158","volume":"70","author":"I See","year":"2020","unstructured":"See I, Mu Y, Albrecht V, Karlsson M, Dumyati G, Hardy DJ, Koeck M, Lynfield R, Nadle J, Ray SM, Schaffner W, Kallen AJ (2020) Trends in incidence of methicillin-resistant Staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure, United States, 2005\u20132013. Clin Infect Dis 70:19\u201325","journal-title":"Clin Infect Dis"},{"key":"8063_CR13","doi-asserted-by":"publisher","unstructured":"Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, Boccia S, Castillo-Polo JA, Magrini E, Garcia-Vello P, Wool E, Gigante V, Duffy E, Cassini A, Huttner B, Pardo PR, Naghavi M, Mirzayev F, Zignol M, Cameron A, Tacconelli E, Group WHOBPPLA, (2025) The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(25)00118-5.","DOI":"10.1016\/S1473-3099(25)00118-5"},{"key":"8063_CR14","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1016\/S2542-5196(23)00127-4","volume":"7","author":"E Rahbe","year":"2023","unstructured":"Rahbe E, Watier L, Guillemot D, Glaser P, Opatowski L (2023) Determinants of worldwide antibiotic resistance dynamics across drug-bacterium pairs: a multivariable spatial-temporal analysis using ATLAS. Lancet Planet Health 7:e547\u2013e557","journal-title":"Lancet Planet Health"},{"key":"8063_CR15","doi-asserted-by":"publisher","first-page":"e0003109","DOI":"10.1371\/journal.pgph.0003109","volume":"4","author":"A Baguiya","year":"2024","unstructured":"Baguiya A, Bonet M, Brizuela V, Cuesta C, Knight M, Lumbiganon P, Abalos E, Kouanda S, Group WHOGMSSR (2024) Infection-related severe maternal outcomes and case fatality rates in 43 low and middle-income countries across the WHO regions: results from the Global Maternal Sepsis Study (GLOSS). PLOS Glob Public Health 4:e0003109","journal-title":"PLOS Glob Public Health"},{"key":"8063_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13613-023-01166-1","volume":"13","author":"R Dong","year":"2023","unstructured":"Dong R, Liu W, Weng L, Yin P, Peng J, Chen Y, Li S, Wang C, Jiang W, Hu X, Du B, Zhou M, China Critical Care Clinical Trials G (2023) Temporal trends of sepsis-related mortality in China, 2006\u20132020: a population-based study. Ann Intensive Care 13:71","journal-title":"Ann Intensive Care"},{"key":"8063_CR17","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00134-016-4602-2","volume":"43","author":"AM Dondorp","year":"2017","unstructured":"Dondorp AM, Hoang MNT, Mer M, Sepsis in Resource-Limited Settings-Expert Consensus Recommendations Group of the European Society of Intensive Care M, the Mahidol-Oxford Research Unit in Bangkok T (2017) Recommendations for the management of severe malaria and severe dengue in resource-limited settings. Intensive Care Med 43:1683\u20131685","journal-title":"Intensive Care Med"},{"key":"8063_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jcrc.2020.04.012","volume":"58","author":"X Ma","year":"2020","unstructured":"Ma X, Vervoort D (2020) Critical care capacity during the COVID-19 pandemic: global availability of intensive care beds. J Crit Care 58:96\u201397","journal-title":"J Crit Care"},{"key":"8063_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070305","volume":"8","author":"ST Jacob","year":"2013","unstructured":"Jacob ST, Pavlinac PB, Nakiyingi L, Banura P, Baeten JM, Morgan K, Magaret A, Manabe Y, Reynolds SJ, Liles WC, Wald A, Joloba ML, Mayanja-Kizza H, Scheld WM (2013) Mycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda-high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score. PLoS ONE 8:e70305","journal-title":"PLoS ONE"},{"key":"8063_CR20","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/S2214-109X(17)30488-6","volume":"6","author":"PO Ouma","year":"2018","unstructured":"Ouma PO, Maina J, Thuranira PN, Macharia PM, Alegana VA, English M, Okiro EA, Snow RW (2018) Access to emergency hospital care provided by the public sector in sub-Saharan Africa in 2015: a geocoded inventory and spatial analysis. Lancet Glob Health 6:e342\u2013e350","journal-title":"Lancet Glob Health"},{"key":"8063_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.4269\/ajtmh.21-0362","volume":"106","author":"I Hossain","year":"2021","unstructured":"Hossain I, Hill P, Bottomley C, Jasseh M, Bojang K, Kaira M, Sankareh A, Sarwar G, Greenwood B, Howie S, Mackenzie G (2021) Healthcare seeking and access to care for pneumonia, sepsis, meningitis, and malaria in rural Gambia. Am J Trop Med Hyg 106:446\u2013453","journal-title":"Am J Trop Med Hyg"},{"key":"8063_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152965","volume":"11","author":"MT Herdman","year":"2016","unstructured":"Herdman MT, Maude RJ, Chowdhury MS, Kingston HW, Jeeyapant A, Samad R, Karim R, Dondorp AM, Hossain MA (2016) The relationship between poverty and healthcare seeking among patients hospitalized with acute febrile illnesses in Chittagong. Bangladesh PLoS One 11:e0152965","journal-title":"Bangladesh PLoS One"},{"key":"8063_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11739-022-03179-3","volume":"18","author":"FR Machado","year":"2023","unstructured":"Machado FR, Cavalcanti AB, Braga MA, Tallo FS, Bossa A, Souza JL, Ferreira JF, Pizzol FD, Monteiro MB, Angus DC, Lisboa T, Azevedo LCP, Spread Ed Investigators tILAdSN (2023) Sepsis in Brazilian emergency departments: a prospective multicenter observational study. Intern Emerg Med 18:409\u2013421","journal-title":"Intern Emerg Med"},{"key":"8063_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0140-6736(24)02846-0","volume":"405","author":"African Critical Illness Outcomes Study I","year":"2025","unstructured":"African Critical Illness Outcomes Study I (2025) The African Critical Illness Outcomes Study (ACIOS): a point prevalence study of critical illness in 22 nations in Africa. Lancet 405:715\u2013724","journal-title":"Lancet"},{"key":"8063_CR25","first-page":"239","volume":"30","author":"FJ da Silva Ramos","year":"2024","unstructured":"da Silva Ramos FJ, Freitas FGR, Machado FR (2024) Boarding in the emergency department: challenges and mitigation strategies. Curr Opin Crit Care 30:239\u2013245","journal-title":"Curr Opin Crit Care"},{"key":"8063_CR26","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1007\/s00134-016-4415-3","volume":"42","author":"CL Thwaites","year":"2016","unstructured":"Thwaites CL, Lundeg G, Dondorp AM, Sepsis in resource-limited settings-expert consensus recommendations group of the European Society of Intensive Care M, the Mahidol-Oxford Research Unit in Bangkok T (2016) Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings. Intensive Care Med 42:2040\u20132042","journal-title":"Intensive Care Med"},{"key":"8063_CR27","doi-asserted-by":"publisher","first-page":"e0142624","DOI":"10.1128\/aac.01426-24","volume":"69","author":"W Cornistein","year":"2025","unstructured":"Cornistein W, Balasini C, Nuccetelli Y, Rodriguez VM, Cudmani N, Roca MV, Sadino G, Brizuela M, Fernandez A, Gonzalez S, Aguila D, Macchi A, Staneloni MI, Estenssoro E, Prevar Study G (2025) Prevalence and mortality associated with multidrug-resistant infections in adult intensive care units in Argentina (PREV-AR). Antimicrob Agents Chemother 69:e0142624","journal-title":"Antimicrob Agents Chemother"},{"key":"8063_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004199","volume":"20","author":"K Allel","year":"2023","unstructured":"Allel K, Stone J, Undurraga EA, Day L, Moore CE, Lin L, Furuya-Kanamori L, Yakob L (2023) The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med 20:e1004199","journal-title":"PLoS Med"},{"key":"8063_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Moller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47:1181\u20131247","journal-title":"Intensive Care Med"},{"key":"8063_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/ACO.0000000000000830","volume":"33","author":"JJ De Waele","year":"2020","unstructured":"De Waele JJ, Boelens J, Leroux-Roels I (2020) Multidrug-resistant bacteria in ICU: fact or myth. Curr Opin Anaesthesiol 33:156\u2013161","journal-title":"Curr Opin Anaesthesiol"},{"key":"8063_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13054-016-1266-9","volume":"20","author":"C Rhee","year":"2016","unstructured":"Rhee C, Kadri SS, Danner RL, Suffredini AF, Massaro AF, Kitch BT, Lee G, Klompas M (2016) Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes. Crit Care 20:89","journal-title":"Crit Care"},{"key":"8063_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00134-022-06956-y","volume":"49","author":"P Povoa","year":"2023","unstructured":"Povoa P, Coelho L, Dal-Pizzol F, Ferrer R, Huttner A, Conway Morris A, Nobre V, Ramirez P, Rouze A, Salluh J, Singer M, Sweeney DA, Torres A, Waterer G, Kalil AC (2023) How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med 49:142\u2013153","journal-title":"Intensive Care Med"},{"key":"8063_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00134-019-05520-5","volume":"45","author":"JF Timsit","year":"2019","unstructured":"Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, Kipnis E, Kollef M, Laupland K, Paiva JA, Rodriguez-Bano J, Ruppe E, Salluh J, Taccone FS, Weiss E, Barbier F (2019) Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med 45:172\u2013189","journal-title":"Intensive Care Med"},{"key":"8063_CR34","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s00134-024-07453-0","volume":"50","author":"L De Bus","year":"2024","unstructured":"De Bus L, Arvaniti K, Sjovall F (2024) Empirical antimicrobials in the intensive care unit. Intensive Care Med 50:1338\u20131341","journal-title":"Intensive Care Med"},{"key":"8063_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13613-020-00713-4","volume":"10","author":"JF Timsit","year":"2020","unstructured":"Timsit JF, Baleine J, Bernard L, Calvino-Gunther S, Darmon M, Dellamonica J, Desruennes E, Leone M, Lepape A, Leroy O, Lucet JC, Merchaoui Z, Mimoz O, Misset B, Parienti JJ, Quenot JP, Roch A, Schmidt M, Slama M, Souweine B, Zahar JR, Zingg W, Bodet-Contentin L, Maxime V (2020) Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit. Ann Intensive Care 10:118","journal-title":"Ann Intensive Care"},{"key":"8063_CR36","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s00134-024-07498-1","volume":"50","author":"N Buetti","year":"2024","unstructured":"Buetti N, Zahar JR, Adda M, Ruckly S, Bruel C, Schwebel C, Darmon M, Adrie C, Cohen Y, Siami S, Laurent V, Souweine B, Timsit JF, Network O (2024) Treatment of positive catheter tip culture without bloodstream infections in critically ill patients. A case-cohort study from the OUTCOMEREA network. Intensive Care Med 50:1108\u20131118","journal-title":"Intensive Care Med"},{"key":"8063_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmi.2019.07.007","volume":"26","author":"KJ Denny","year":"2020","unstructured":"Denny KJ, De Waele J, Laupland KB, Harris PNA, Lipman J (2020) When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit. Clin Microbiol Infect 26:35\u201340","journal-title":"Clin Microbiol Infect"},{"key":"8063_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S1473-3099(12)70151-2","volume":"12","author":"T Hranjec","year":"2012","unstructured":"Hranjec T, Rosenberger LH, Swenson B, Metzger R, Flohr TR, Politano AD, Riccio LM, Popovsky KA, Sawyer RG (2012) Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis 12:774\u2013780","journal-title":"Lancet Infect Dis"},{"key":"8063_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13613-024-01243-z","volume":"14","author":"M Martin","year":"2024","unstructured":"Martin M, Forveille S, Lascarrou JB, Seguin A, Canet E, Lemarie J, Agbakou M, Desmedt L, Blonz G, Zambon O, Corvec S, Le Thuaut A, Reignier J (2024) Immediate vs culture-initiated antibiotic therapy in suspected non-severe ventilator-associated pneumonia: a before-after study (DELAVAP). Ann Intensive Care 14:33","journal-title":"Ann Intensive Care"},{"key":"8063_CR40","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1093\/jac\/dkae157","volume":"79","author":"H Zhou","year":"2024","unstructured":"Zhou H, Buetti N, Perez-Galera S, Bravo-Ferrer J, Gutierrez-Gutierrez B, Paniagua-Garcia M, Feifel J, Sauser J, Kostyanev T, Canton R, Tan LK, Basoulis D, Pintado V, Roilides E, Dragovac G, Torre-Cisneros J, Medic D, Akova M, Goossens H, Bonten M, Harbarth S, Rodriguez-Bano J, De Kraker MEA, team C-Ep (2024) Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study. J Antimicrob Chemother 79:2132\u20132141","journal-title":"J Antimicrob Chemother"},{"key":"8063_CR41","doi-asserted-by":"publisher","first-page":"298 e291","DOI":"10.1016\/j.cmi.2021.06.031","volume":"28","author":"M Falcone","year":"2022","unstructured":"Falcone M, Tiseo G, Galfo V, Giordano C, Leonildi A, Marciano E, De Simone P, Biancofiore G, Boggi U, Barnini S, Menichetti F, Italian Group of Antimicrobial S (2022) Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study). Clin Microbiol Infect 28:298 e291-298 e297","journal-title":"Clin Microbiol Infect"},{"key":"8063_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00134-021-06606-9","volume":"48","author":"S Hraiech","year":"2022","unstructured":"Hraiech S, Pauly V, Orleans V, Auquier P, Boyer L, Papazian L, Azoulay E (2022) Undocumented migrants in French intensive care units in 2011\u20132018: retrospective nationwide study. Intensive Care Med 48:290\u2013299","journal-title":"Intensive Care Med"},{"key":"8063_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13613-023-01197-8","volume":"13","author":"S Hraiech","year":"2023","unstructured":"Hraiech S, Pauly V, Orleans V, Auquier P, Azoulay E, Roch A, Boyer L, Papazian L (2023) COVID-19 among undocumented migrants admitted to French intensive care units during the 2020\u20132021 period: a retrospective nationwide study. Ann Intensive Care 13:99","journal-title":"Ann Intensive Care"},{"key":"8063_CR44","doi-asserted-by":"publisher","unstructured":"Zanotti P, Odolini S, Tomasoni LR, Grecchi C, Caligaris S, Gulletta M, Matteelli A, Cappa V, Castelli F, (2018) Imported malaria in northern Italy: epidemiology and clinical features observed over 18 years in the Teaching Hospital of Brescia. J Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tax081","DOI":"10.1093\/jtm\/tax081"},{"key":"8063_CR45","doi-asserted-by":"publisher","first-page":"100001","DOI":"10.1016\/j.lanepe.2020.100001","volume":"1","author":"MP Grobusch","year":"2021","unstructured":"Grobusch MP, Weld L, Goorhuis A, Hamer DH, Schunk M, Jordan S, Mockenhaupt FP, Chappuis F, Asgeirsson H, Caumes E, Jensenius M, van Genderen PJJ, Castelli F, Lopez-Velez R, Field V, Bottieau E, Molina I, Rapp C, Menendez MD, Gkrania-Klotsas E, Larsen CS, Malvy D, Lalloo D, Gobbi F, Florescu SA, Gautret P, Schlagenhauf P (2021) Travel-related infections presenting in Europe: a 20-year analysis of EuroTravNet surveillance data. Lancet Reg Health Eur 1:100001","journal-title":"Lancet Reg Health Eur"},{"key":"8063_CR46","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1001\/archinte.166.15.1642","volume":"166","author":"E Bottieau","year":"2006","unstructured":"Bottieau E, Clerinx J, Schrooten W, Van den Enden E, Wouters R, Van Esbroeck M, Vervoort T, Demey H, Colebunders R, Van Gompel A, Van den Ende J (2006) Etiology and outcome of fever after a stay in the tropics. Arch Intern Med 166:1642\u20131648","journal-title":"Arch Intern Med"},{"key":"8063_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jcrc.2018.03.025","volume":"46","author":"DR Karnad","year":"2018","unstructured":"Karnad DR, Richards GA, Silva GS, Amin P, Council of the World Federation of Societies of I, Critical Care M (2018) Tropical diseases in the ICU: a syndromic approach to diagnosis and treatment. J Crit Care 46:119\u2013126","journal-title":"J Crit Care"},{"key":"8063_CR48","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2478\/jtim-2022-0042","volume":"10","author":"PJ Herten","year":"2022","unstructured":"Herten PJ, Vlieghe E, Bottieau E, Florence E, Jorens PG (2022) The emergence of travel-related infections in critical care units. J Transl Int Med 10:328\u2013339","journal-title":"J Transl Int Med"},{"key":"8063_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-025-00614-5","volume":"11","author":"S Rajapakse","year":"2025","unstructured":"Rajapakse S, Fernando N, Dreyfus A, Smith C, Rodrigo C (2025) Leptospirosis. Nat Rev Dis Primers 11:32","journal-title":"Nat Rev Dis Primers"},{"key":"8063_CR50","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jama.2023.28019","volume":"331","author":"ML Martinson","year":"2024","unstructured":"Martinson ML, Lapham J (2024) Prevalence of immunosuppression among US adults. JAMA 331:880\u2013882","journal-title":"JAMA"},{"key":"8063_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13054-024-05073-0","volume":"28","author":"JL Nates","year":"2024","unstructured":"Nates JL, Pene F, Darmon M, Mokart D, Castro P, David S, Povoa P, Russell L, Nielsen ND, Gorecki GP, Gradel KO, Azoulay E, Bauer PR, Nine II (2024) Septic shock in the immunocompromised cancer patient: a narrative review. Crit Care 28:285","journal-title":"Crit Care"},{"key":"8063_CR52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/cid\/ciw295","volume":"63","author":"JP Donnelly","year":"2016","unstructured":"Donnelly JP, Locke JE, MacLennan PA, McGwin G Jr, Mannon RB, Safford MM, Baddley JW, Muntner P, Wang HE (2016) Inpatient mortality among solid organ transplant recipients hospitalized for sepsis and severe sepsis. Clin Infect Dis 63:186\u2013194","journal-title":"Clin Infect Dis"},{"key":"8063_CR53","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","volume":"46","author":"E Azoulay","year":"2020","unstructured":"Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P, Montero JG, Loeches IM, Mehta S, Puxty K, Schellongowski P, Rello J, Mokart D, Lemiale V, Mirouse A, Nine-i I (2020) Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med 46:298\u2013314","journal-title":"Intensive Care Med"},{"key":"8063_CR54","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/cid\/ciy723","volume":"68","author":"MF Di Pasquale","year":"2019","unstructured":"Di Pasquale MF, Sotgiu G, Gramegna A, Radovanovic D, Terraneo S, Reyes LF, Rupp J, Gonzalez Del Castillo J, Blasi F, Aliberti S, Restrepo MI, Investigators G (2019) Prevalence and etiology of community-acquired pneumonia in immunocompromised patients. Clin Infect Dis 68:1482\u20131493","journal-title":"Clin Infect Dis"},{"key":"8063_CR55","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00134-023-07295-2","volume":"50","author":"L Kreitmann","year":"2024","unstructured":"Kreitmann L, Helms J, Martin-Loeches I, Salluh J, Poulakou G, Pene F, Nseir S (2024) ICU-acquired infections in immunocompromised patients. Intensive Care Med 50:332\u2013349","journal-title":"Intensive Care Med"},{"key":"8063_CR56","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1093\/jac\/dkx315","volume":"72","author":"M Ripa","year":"2017","unstructured":"Ripa M, Rodriguez-Nunez O, Cardozo C, Naharro-Abellan A, Almela M, Marco F, Morata L, De La Calle C, Del Rio A, Garcia-Vidal C, Ortega MDM, Guerrero-Leon MLA, Feher C, Torres B, Puerta-Alcalde P, Mensa J, Soriano A, Martinez JA (2017) Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis. J Antimicrob Chemother 72:3443\u20133452","journal-title":"J Antimicrob Chemother"},{"key":"8063_CR57","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/cid\/ciz223","volume":"69","author":"V Fabre","year":"2019","unstructured":"Fabre V, Amoah J, Cosgrove SE, Tamma PD (2019) Antibiotic therapy for Pseudomonas aeruginosa bloodstream infections: how long is long enough? Clin Infect Dis 69:2011\u20132014","journal-title":"Clin Infect Dis"},{"key":"8063_CR58","doi-asserted-by":"publisher","first-page":"1800193","DOI":"10.2807\/1560-7917.ES.2019.24.4.1800193","volume":"24","author":"B Rodriguez-Sanchez","year":"2019","unstructured":"Rodriguez-Sanchez B, Cercenado E, Coste AT, Greub G (2019) Review of the impact of MALDI-TOF MS in public health and hospital hygiene, 2018. Euro Surveill 24:1800193","journal-title":"Euro Surveill"},{"key":"8063_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11908-021-00755-0","volume":"23","author":"AM Peri","year":"2021","unstructured":"Peri AM, Stewart A, Hume A, Irwin A, Harris PNA (2021) New microbiological techniques for the diagnosis of bacterial infections and sepsis in ICU including point of care. Curr Infect Dis Rep 23:12","journal-title":"Curr Infect Dis Rep"},{"key":"8063_CR60","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/cid\/civ447","volume":"61","author":"R Banerjee","year":"2015","unstructured":"Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, Shah ND, Mandrekar JN, Patel R (2015) Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 61:1071\u20131080","journal-title":"Clin Infect Dis"},{"key":"8063_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cid\/ciw649","volume":"64","author":"TT Timbrook","year":"2017","unstructured":"Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL (2017) The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis 64:15\u201323","journal-title":"Clin Infect Dis"},{"key":"8063_CR62","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/cid\/ciac354","volume":"75","author":"MJ Satlin","year":"2022","unstructured":"Satlin MJ, Chen L, Gomez-Simmonds A, Marino J, Weston G, Bhowmick T, Seo SK, Sperber SJ, Kim AC, Eilertson B, Derti S, Jenkins SG, Levi MH, Weinstein MP, Tang YW, Hong T, Juretschko S, Hoffman KL, Walsh TJ, Westblade LF, Uhlemann AC, Kreiswirth BN (2022) Impact of a rapid molecular test for klebsiella pneumoniae carbapenemase and ceftazidime-avibactam use on outcomes after bacteremia caused by carbapenem-resistant enterobacterales. Clin Infect Dis 75:2066\u20132075","journal-title":"Clin Infect Dis"},{"key":"8063_CR63","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/cid\/ciae234","volume":"79","author":"AM Peri","year":"2024","unstructured":"Peri AM, Chatfield MD, Ling W, Furuya-Kanamori L, Harris PNA, Paterson DL (2024) Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: what is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis. Clin Infect Dis 79:502\u2013515","journal-title":"Clin Infect Dis"},{"key":"8063_CR64","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00134-024-07772-2","volume":"51","author":"VI Enne","year":"2025","unstructured":"Enne VI, Stirling S, Barber JA, High J, Russell C, Brealey D, Dhesi Z, Colles A, Singh S, Parker R, Peters M, Cherian BP, Riley P, Dryden M, Simpson R, Patel N, Cassidy J, Martin D, Welters ID, Page V, Kandil H, Tudtud E, Turner D, Horne R, O\u2019Grady J, Swart AM, Livermore DM, Gant V, Group IWS, Committees (2025) INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia. Intensive Care Med 51:272\u2013286","journal-title":"Intensive Care Med"},{"key":"8063_CR65","doi-asserted-by":"publisher","unstructured":"Voiriot G, Argaud L, Cohen Y et al (2025) Combined use of a multiplex PCR and serum procalcitonin to reduce antibiotic exposure in critically ill patients with community-acquired pneumonia: the MULTI-CAP randomized controlled trial. Intensive Care Med 51:1417\u20131430. https:\/\/doi.org\/10.1007\/s00134-025-08026-5","DOI":"10.1007\/s00134-025-08026-5"},{"key":"8063_CR66","volume":"7","author":"Y Aissaoui","year":"2025","unstructured":"Aissaoui Y, Derkaoui A, Hachimi A, Bouchama A, Dendane T, Doumiri M, ElAidaoui K, Ziadi A, Essafti M, Oualili L, Khaddouri M, Mroune O, Oudrhiri Safiani M, Khallouki M, Berdai A, Boukatta B, El Adib AR, Madani N, Soraa N, Belhadj A, Kohen JE, Abouqal R (2025) Diagnostic performance and impact on antimicrobial treatment of a multiplex polymerase chain reaction in critically ill patients with pneumonia: a multicenter observational study (the MORICUP-PCR study: morocco ICU pneumonia-PCR study). Crit Care Explor 7:e1220","journal-title":"Crit Care Explor"},{"key":"8063_CR67","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s00134-022-06722-0","volume":"48","author":"A Conway Morris","year":"2022","unstructured":"Conway Morris A, Bos LDJ, Nseir S (2022) Molecular diagnostics in severe pneumonia: a new dawn or false promise? Intensive Care Med 48:740\u2013742","journal-title":"Intensive Care Med"},{"key":"8063_CR68","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1097\/CCM.0000000000000516","volume":"42","author":"C Vazquez-Guillamet","year":"2014","unstructured":"Vazquez-Guillamet C, Scolari M, Zilberberg MD, Shorr AF, Micek ST, Kollef M (2014) Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med 42:2342\u20132349","journal-title":"Crit Care Med"},{"key":"8063_CR69","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.chest.2020.03.087","volume":"158","author":"EJ Zasowski","year":"2020","unstructured":"Zasowski EJ, Bassetti M, Blasi F, Goossens H, Rello J, Sotgiu G, Tavoschi L, Arber MR, McCool R, Patterson JV, Longshaw CM, Lopes S, Manissero D, Nguyen ST, Tone K, Aliberti S (2020) A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections. Chest 158:929\u2013938","journal-title":"Chest"},{"key":"8063_CR70","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.cmi.2024.09.011","volume":"30","author":"A Loiodice","year":"2024","unstructured":"Loiodice A, Bailly S, Ruckly S, Buetti N, Barbier F, Staiquly Q, Tabah A, Timsit JF, Eurobact-2 Study Group tESoICMtESoCMtIDSGfIiCIP, the ON (2024) Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study. Clin Microbiol Infect 30:1559\u20131568","journal-title":"Clin Microbiol Infect"},{"key":"8063_CR71","doi-asserted-by":"publisher","first-page":"1900057","DOI":"10.1183\/13993003.00057-2019","volume":"54","author":"BJ Webb","year":"2019","unstructured":"Webb BJ, Sorensen J, Jephson A, Mecham I, Dean NC (2019) Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study. Eur Respir J 54:1900057","journal-title":"Eur Respir J"},{"key":"8063_CR72","doi-asserted-by":"publisher","unstructured":"Chanderraj R, Baker JM, Kay SG, Brown CA, Hinkle KJ, Fergle DJ, McDonald RA, Falkowski NR, Metcalf JD, Kaye KS, Woods RJ, Prescott HC, Sjoding MW, Dickson RP, (2023) In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. Eur Respir J 61(2):2200910. https:\/\/doi.org\/10.1183\/13993003.00910-2022","DOI":"10.1183\/13993003.00910-2022"},{"key":"8063_CR73","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2899","volume":"3","author":"C Rhee","year":"2020","unstructured":"Rhee C, Kadri SS, Dekker JP, Danner RL, Chen HC, Fram D, Zhang F, Wang R, Klompas M, Program CDCPE (2020) Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3:e202899","journal-title":"JAMA Netw Open"},{"key":"8063_CR74","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","volume":"40","author":"M Leone","year":"2014","unstructured":"Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanese J, Jaber S, Lepape A, Constantin JM, Papazian L, Bruder N, Allaouchiche B, Bezulier K, Antonini F, Textoris J, Martin C, Investigators AN (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40:1399\u20131408","journal-title":"Intensive Care Med"},{"key":"8063_CR75","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1473-3099(23)00686-2","volume":"24","author":"LE Lopez-Cortes","year":"2024","unstructured":"Lopez-Cortes LE, Delgado-Valverde M, Moreno-Mellado E, Goikoetxea Aguirre J, Guio Carrion L, Blanco Vidal MJ, Lopez Soria LM, Perez-Rodriguez MT, Martinez Lamas L, Revillas FADL, Arminanzas C, Ruiz de Alegria-Puig C, Jimenez Aguilar P, Martinez-Rubio MDC, Saez-Bejar C, Cuevas CDL, Martin-Aspas A, Galan F, Yuste JR, Leiva-Leon J, Bou G, Capon Gonzalez P, Boix-Palop L, Xercavins-Valls M, Goenaga-Sanchez MA, Anza DV, Caston JJ, Rufian MR, Merino E, Rodriguez JC, Loeches B, Cuervo G, Guerra Laso JM, Plata A, Perez Cortes S, Lopez Mato P, Sierra Monzon JL, Rosso-Fernandez C, Bravo-Ferrer JM, Retamar-Gentil P, Rodriguez-Bano J, Group SS (2024) Efficacy and safety of a structured de-escalation from antipseudomonal beta-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial. Lancet Infect Dis 24:375\u2013385","journal-title":"Lancet Infect Dis"},{"key":"8063_CR76","doi-asserted-by":"publisher","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA (2024) Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciae403","DOI":"10.1093\/cid\/ciae403"},{"key":"8063_CR77","doi-asserted-by":"publisher","unstructured":"Kaye KS, Marchaim D, Thamlikitkul V, Carmeli Y, Chiu CH, Daikos G, Dhar S, Durante-Mangoni E, Gikas A, Kotanidou A, Paul M, Roilides E, Rybak M, Samarkos M, Sims M, Tancheva D, Tsiodras S, Kett D, Patel G, Calfee D, Leibovici L, Power L, Munoz-Price S, Stevenson K, Susick L, Latack K, Daniel J, Chiou C, Divine GW, Ghazyaran V, Pogue JM (2023) Colistin monotherapy versus combination therapy for carbapenem-resistant organisms. NEJM Evid 2(1). https:\/\/doi.org\/10.1056\/EVIDoa2200131","DOI":"10.1056\/EVIDoa2200131"},{"key":"8063_CR78","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","volume":"18","author":"M Paul","year":"2018","unstructured":"Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L (2018) Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. Lancet Infect Dis 18:391\u2013400","journal-title":"Lancet Infect Dis"},{"key":"8063_CR79","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1055\/s-0034-1398490","volume":"36","author":"MH Abdul-Aziz","year":"2015","unstructured":"Abdul-Aziz MH, Lipman J, Mouton JW, Hope WW, Roberts JA (2015) Applying pharmacokinetic\/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development. Semin Respir Crit Care Med 36:136\u2013153","journal-title":"Semin Respir Crit Care Med"},{"key":"8063_CR80","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","volume":"14","author":"JA Roberts","year":"2014","unstructured":"Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL, International Society of Anti-Infective P, the P, Pharmacodynamics Study Group of the European Society of Clinical M, Infectious D (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis 14:498\u2013509","journal-title":"Lancet Infect Dis"},{"key":"8063_CR81","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/CCM.0000000000002210","volume":"45","author":"JA Roberts","year":"2017","unstructured":"Roberts JA, Kumar A, Lipman J (2017) Right Dose, Right Now: Customized Drug Dosing in the Critically Ill. Crit Care Med 45:331\u2013336","journal-title":"Crit Care Med"},{"key":"8063_CR82","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrneph.2011.92","volume":"7","author":"AA Udy","year":"2011","unstructured":"Udy AA, Roberts JA, Lipman J (2011) Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol 7:539\u2013543","journal-title":"Nat Rev Nephrol"},{"key":"8063_CR83","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jama.2024.9803","volume":"332","author":"MH Abdul-Aziz","year":"2024","unstructured":"Abdul-Aziz MH, Hammond NE, Brett SJ, Cotta MO, De Waele JJ, Devaux A, Di Tanna GL, Dulhunty JM, Elkady H, Eriksson L, Hasan MS, Khan AB, Lipman J, Liu X, Monti G, Myburgh J, Novy E, Omar S, Rajbhandari D, Roger C, Sjovall F, Zaghi I, Zangrillo A, Delaney A, Roberts JA (2024) Prolonged vs intermittent infusions of beta-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis. JAMA 332:638\u2013648","journal-title":"JAMA"},{"key":"8063_CR84","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.2024.9779","volume":"332","author":"JM Dulhunty","year":"2024","unstructured":"Dulhunty JM, Brett SJ, De Waele JJ, Rajbhandari D, Billot L, Cotta MO, Davis JS, Finfer S, Hammond NE, Knowles S, Liu X, McGuinness S, Mysore J, Paterson DL, Peake S, Rhodes A, Roberts JA, Roger C, Shirwadkar C, Starr T, Taylor C, Myburgh JA, Lipman J, Investigators BIS (2024) Continuous vs intermittent beta-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial. JAMA 332:629\u2013637","journal-title":"JAMA"},{"key":"8063_CR85","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1473-3099(17)30615-1","volume":"18","author":"KZ Vardakas","year":"2018","unstructured":"Vardakas KZ, Voulgaris GL, Maliaros A, Samonis G, Falagas ME (2018) Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis 18:108\u2013120","journal-title":"Lancet Infect Dis"},{"key":"8063_CR86","unstructured":"Yixuan l, Roberts JA, Abdul-Aziz MH, Sime FB, (2025) Continuous or extended versus intermittent i 1 nfusions of beta-lactam antibiotics in ICU patients with pneumonia: a systematic review and meta-analysis of randomized controlled trials. Antimicrob Agents Chemother: in press"},{"key":"8063_CR87","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"MH Abdul-Aziz","year":"2020","unstructured":"Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, Neely MN, Paiva JA, Pea F, Sjovall F, Timsit JF, Udy AA, Wicha SG, Zeitlinger M, De Waele JJ, Roberts JA, Infection Section of European Society of Intensive Care M, Pharmacokinetic\/pharmacodynamic, Critically Ill Patient Study Groups of European Society of Clinical M, Infectious D, Infectious Diseases Group of International Association of Therapeutic Drug M, Clinical T, Infections in the ICU, Sepsis Working Group of International Society of Antimicrobial C (2020) Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper(). Intensive Care Med 46:1127\u20131153","journal-title":"Intensive Care Med"},{"key":"8063_CR88","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/CCM.0000000000002827","volume":"46","author":"G Leguelinel-Blache","year":"2018","unstructured":"Leguelinel-Blache G, Nguyen TL, Louart B, Poujol H, Lavigne JP, Roberts JA, Muller L, Kinowski JM, Roger C, Lefrant JY (2018) Impact of quality bundle enforcement by a critical care pharmacist on patient outcome and costs. Crit Care Med 46:199\u2013207","journal-title":"Crit Care Med"},{"key":"8063_CR89","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00134-024-07348-0","volume":"50","author":"N Buetti","year":"2024","unstructured":"Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, Aslan AT, Leone M, Bassetti M, Morris AC, Arvaniti K, Paiva JA, Ferrer R, Qiu H, Montrucchio G, Cortegiani A, Kayaaslan B, De Bus L, De Waele JJ, Timsit JF, Eurobact-2 Study Group tESoICMtESoCMtIDSGfIiCIP, the ON (2024) The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections. Intensive Care Med 50:873\u2013889","journal-title":"Intensive Care Med"},{"key":"8063_CR90","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/jac\/dkac101","volume":"77","author":"T Luxton","year":"2022","unstructured":"Luxton T, King N, Walti C, Jeuken L, Sandoe J (2022) A systematic review of the effect of therapeutic drug monitoring on patient health outcomes during treatment with penicillins. J Antimicrob Chemother 77:1532\u20131541","journal-title":"J Antimicrob Chemother"},{"key":"8063_CR91","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1093\/cid\/ciac506","volume":"75","author":"R Pai Mangalore","year":"2022","unstructured":"Pai Mangalore R, Ashok A, Lee SJ, Romero L, Peel TN, Udy AA, Peleg AY (2022) Beta-lactam antibiotic therapeutic drug monitoring in critically ill patients: a systematic review and meta-analysis. Clin Infect Dis 75:1848\u20131860","journal-title":"Clin Infect Dis"},{"key":"8063_CR92","doi-asserted-by":"publisher","unstructured":"Novy E, Martiniere H, Roger C (2023) The current status and future perspectives of beta-lactam therapeutic drug monitoring in critically ill patients. Antibiotics 12(4):681. https:\/\/doi.org\/10.3390\/antibiotics12040681","DOI":"10.3390\/antibiotics12040681"},{"key":"8063_CR93","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00134-021-06609-6","volume":"48","author":"S Hagel","year":"2022","unstructured":"Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, Hohn A, Weigand M, Michels G, Kluge S, Nierhaus A, Jarczak D, Konig C, Weismann D, Frey O, Witzke D, Muller C, Bauer M, Kiehntopf M, Neugebauer S, Lehmann T, Roberts JA, Pletz MW, Investigators TT (2022) Effect of therapeutic drug monitoring-based dose optimization of piperacillin\/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. Intensive Care Med 48:311\u2013321","journal-title":"Intensive Care Med"},{"key":"8063_CR94","volume":"42","author":"MG Chai","year":"2023","unstructured":"Chai MG, Roberts JA, Kelly CF, Ungerer JPJ, McWhinney BC, Lipman J, Farkas A, Cotta MO (2023) Efficiency of dosing software using Bayesian forecasting in achieving target antibiotic exposures in critically ill patients, a prospective cohort study. Anaesth Crit Care Pain Med 42:101296","journal-title":"Anaesth Crit Care Pain Med"},{"key":"8063_CR95","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/QCO.0000000000000945","volume":"36","author":"AA Theodosiou","year":"2023","unstructured":"Theodosiou AA, Jones CE, Read RC, Bogaert D (2023) Microbiotoxicity: antibiotic usage and its unintended harm to the microbiome. Curr Opin Infect Dis 36:371\u2013378","journal-title":"Curr Opin Infect Dis"},{"key":"8063_CR96","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jiac.2018.08.004","volume":"24","author":"K Eljaaly","year":"2018","unstructured":"Eljaaly K, Enani MA, Al-Tawfiq JA (2018) Impact of carbapenem versus non-carbapenem treatment on the rates of superinfection: a meta-analysis of randomized controlled trials. J Infect Chemother 24:915\u2013920","journal-title":"J Infect Chemother"},{"key":"8063_CR97","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1513\/AnnalsATS.201809-646PS","volume":"16","author":"HC Prescott","year":"2019","unstructured":"Prescott HC, Iwashyna TJ (2019) Improving sepsis treatment by embracing diagnostic uncertainty. Ann Am Thorac Soc 16:426\u2013429","journal-title":"Ann Am Thorac Soc"},{"key":"8063_CR98","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet A, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 16:819\u2013827","journal-title":"Lancet Infect Dis"},{"key":"8063_CR99","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","volume":"177","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE (2017) Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 177:1308\u20131315","journal-title":"JAMA Intern Med"},{"key":"8063_CR100","doi-asserted-by":"publisher","unstructured":"Webb BJ, Subramanian A, Lopansri B, Goodman B, Jones PB, Ferraro J, Stenehjem E, Brown SM (2020) Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection. Antimicrob Agents Chemother 64. https:\/\/doi.org\/10.1128\/aac.02169-19","DOI":"10.1128\/aac.02169-19"},{"key":"8063_CR101","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1086\/430912","volume":"41","author":"IA Bliziotis","year":"2005","unstructured":"Bliziotis IA, Samonis G, Vardakas KZ, Chrysanthopoulou S, Falagas ME (2005) Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis 41:149\u2013158","journal-title":"Clin Infect Dis"},{"key":"8063_CR102","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cmi.2021.10.022","volume":"28","author":"J Curran","year":"2022","unstructured":"Curran J, Lo J, Leung V, Brown K, Schwartz KL, Daneman N, Garber G, Wu JHC, Langford BJ (2022) Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis. Clin Microbiol Infect 28:479\u2013490","journal-title":"Clin Microbiol Infect"},{"key":"8063_CR103","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00134-020-05929-3","volume":"46","author":"N Arulkumaran","year":"2020","unstructured":"Arulkumaran N, Routledge M, Schlebusch S, Lipman J, Conway Morris A (2020) Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med 46:225\u2013235","journal-title":"Intensive Care Med"},{"key":"8063_CR104","doi-asserted-by":"publisher","unstructured":"Roger C, Louart B (2021) Beta-lactams toxicity in the intensive care unit: an underestimated collateral damage? Microorganisms 9(7):1505. https:\/\/doi.org\/10.3390\/microorganisms9071505","DOI":"10.3390\/microorganisms9071505"},{"key":"8063_CR105","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13054-017-1856-1","volume":"21","author":"LE Payne","year":"2017","unstructured":"Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, Fraser GL (2017) Cefepime-induced neurotoxicity: a systematic review. Crit Care 21:276","journal-title":"Crit Care"},{"key":"8063_CR106","doi-asserted-by":"publisher","unstructured":"Blevins AM, Lashinsky JN, McCammon C, Kollef M, Micek S, Juang P (2019) Incidence of acute kidney injury in critically ill patients receiving vancomycin with concomitant piperacillin-tazobactam, cefepime, or meropenem. Antimicrob Agents Chemother 63:10.1128\/aac.02658-18. https:\/\/doi.org\/10.1128\/aac.02658-18","DOI":"10.1128\/aac.02658-18"},{"key":"8063_CR107","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41579-023-00936-9","volume":"21","author":"L de Nies","year":"2023","unstructured":"de Nies L, Kobras CM, Stracy M (2023) Antibiotic-induced collateral damage to the microbiota and associated infections. Nat Rev Microbiol 21:789\u2013804","journal-title":"Nat Rev Microbiol"},{"key":"8063_CR108","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bcp.2016.09.007","volume":"134","author":"M Ferrer","year":"2017","unstructured":"Ferrer M, Mendez-Garcia C, Rojo D, Barbas C, Moya A (2017) Antibiotic use and microbiome function. Biochem Pharmacol 134:114\u2013126","journal-title":"Biochem Pharmacol"},{"key":"8063_CR109","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s41564-018-0257-9","volume":"3","author":"A Palleja","year":"2018","unstructured":"Palleja A, Mikkelsen KH, Forslund SK, Kashani A, Allin KH, Nielsen T, Hansen TH, Liang S, Feng Q, Zhang C, Pyl PT, Coelho LP, Yang H, Wang J, Typas A, Nielsen MF, Nielsen HB, Bork P, Wang J, Vilsboll T, Hansen T, Knop FK, Arumugam M, Pedersen O (2018) Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol 3:1255\u20131265","journal-title":"Nat Microbiol"},{"key":"8063_CR110","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41467-022-28525-z","volume":"13","author":"M Reyman","year":"2022","unstructured":"Reyman M, van Houten MA, Watson RL, Chu M, Arp K, de Waal WJ, Schiering I, Plotz FB, Willems RJL, van Schaik W, Sanders EAM, Bogaert D (2022) Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial. Nat Commun 13:893","journal-title":"Nat Commun"},{"key":"8063_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110649","volume":"39","author":"WE Anthony","year":"2022","unstructured":"Anthony WE, Wang B, Sukhum KV, D\u2019Souza AW, Hink T, Cass C, Seiler S, Reske KA, Coon C, Dubberke ER, Burnham CD, Dantas G, Kwon JH (2022) Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults. Cell Rep 39:110649","journal-title":"Cell Rep"},{"key":"8063_CR112","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.abg9868","volume":"375","author":"M Stracy","year":"2022","unstructured":"Stracy M, Snitser O, Yelin I, Amer Y, Parizade M, Katz R, Rimler G, Wolf T, Herzel E, Koren G, Kuint J, Foxman B, Chodick G, Shalev V, Kishony R (2022) Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections. Science 375:889\u2013894","journal-title":"Science"},{"key":"8063_CR113","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1038\/s41467-023-39416-2","volume":"14","author":"J Diaz Caballero","year":"2023","unstructured":"Diaz Caballero J, Wheatley RM, Kapel N, Lopez-Causape C, Van der Schalk T, Quinn A, Shaw LP, Ogunlana L, Recanatini C, Xavier BB, Timbermont L, Kluytmans J, Ruzin A, Esser M, Malhotra-Kumar S, Oliver A, MacLean RC (2023) Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients. Nat Commun 14:4083","journal-title":"Nat Commun"},{"key":"8063_CR114","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202010116","volume":"17","author":"M Zimmermann","year":"2021","unstructured":"Zimmermann M, Patil KR, Typas A, Maier L (2021) Towards a mechanistic understanding of reciprocal drug-microbiome interactions. Mol Syst Biol 17:e10116","journal-title":"Mol Syst Biol"},{"key":"8063_CR115","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-021-03986-2","volume":"599","author":"L Maier","year":"2021","unstructured":"Maier L, Goemans CV, Wirbel J, Kuhn M, Eberl C, Pruteanu M, Muller P, Garcia-Santamarina S, Cacace E, Zhang B, Gekeler C, Banerjee T, Anderson EE, Milanese A, Lober U, Forslund SK, Patil KR, Zimmermann M, Stecher B, Zeller G, Bork P, Typas A (2021) Unravelling the collateral damage of antibiotics on gut bacteria. Nature 599:120\u2013124","journal-title":"Nature"},{"key":"8063_CR116","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1172\/JCI43918","volume":"120","author":"C Ubeda","year":"2010","unstructured":"Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND, van den Brink MR, Kamboj M, Pamer EG (2010) Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120:4332\u20134341","journal-title":"J Clin Invest"},{"key":"8063_CR117","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41591-019-0709-7","volume":"26","author":"B Zhai","year":"2020","unstructured":"Zhai B, Ola M, Rolling T, Tosini NL, Joshowitz S, Littmann ER, Amoretti LA, Fontana E, Wright RJ, Miranda E, Veelken CA, Morjaria SM, Peled JU, van den Brink MRM, Babady NE, Butler G, Taur Y, Hohl TM (2020) High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis. Nat Med 26:59\u201364","journal-title":"Nat Med"},{"key":"8063_CR118","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1128\/AAC.01927-15","volume":"60","author":"M Falcone","year":"2016","unstructured":"Falcone M, Russo A, Iraci F, Carfagna P, Goldoni P, Vullo V, Venditti M (2016) Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection. Antimicrob Agents Chemother 60:252\u2013257","journal-title":"Antimicrob Agents Chemother"},{"key":"8063_CR119","doi-asserted-by":"publisher","first-page":"192ra185","DOI":"10.1126\/scitranslmed.3006055","volume":"5","author":"S Kalghatgi","year":"2013","unstructured":"Kalghatgi S, Spina CS, Costello JC, Liesa M, Morones-Ramirez JR, Slomovic S, Molina A, Shirihai OS, Collins JJ (2013) Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells. Sci Transl Med 5:192ra185","journal-title":"Sci Transl Med"},{"key":"8063_CR120","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ni.3398","volume":"17","author":"SC Cheng","year":"2016","unstructured":"Cheng SC, Scicluna BP, Arts RJ, Gresnigt MS, Lachmandas E, Giamarellos-Bourboulis EJ, Kox M, Manjeri GR, Wagenaars JA, Cremer OL, Leentjens J, van der Meer AJ, van de Veerdonk FL, Bonten MJ, Schultz MJ, Willems PH, Pickkers P, Joosten LA, van der Poll T, Netea MG (2016) Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol 17:406\u2013413","journal-title":"Nat Immunol"},{"key":"8063_CR121","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","volume":"6","author":"M Balouiri","year":"2016","unstructured":"Balouiri M, Sadiki M, Ibnsouda SK (2016) Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal 6:71\u201379","journal-title":"J Pharm Anal"},{"key":"8063_CR122","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1097\/CCM.0b013e3182515190","volume":"40","author":"YC Chuang","year":"2012","unstructured":"Chuang YC, Chang SC, Wang WK (2012) Using the rate of bacterial clearance determined by real-time polymerase chain reaction as a timely surrogate marker to evaluate the appropriateness of antibiotic usage in critical patients with Acinetobacter baumannii bacteremia. Crit Care Med 40:2273\u20132280","journal-title":"Crit Care Med"},{"key":"8063_CR123","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00134-023-07108-6","volume":"49","author":"M Jeffrey","year":"2023","unstructured":"Jeffrey M, Denny KJ, Lipman J, Conway Morris A (2023) Differentiating infection, colonisation, and sterile Inflammation in critical illness: the emerging role of host-response profiling. Intensive Care Med 49:760\u2013771","journal-title":"Intensive Care Med"},{"key":"8063_CR124","doi-asserted-by":"publisher","unstructured":"Nielsen ND, Dean JT, 3rd, Shald EA, Conway Morris A, Povoa P, Schouten J, Parchim N (2024) When to Stop Antibiotics in the Critically Ill? Antibiotics 13(3):272. https:\/\/doi.org\/10.3390\/antibiotics13030272","DOI":"10.3390\/antibiotics13030272"},{"key":"8063_CR125","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/cid\/ciy1134","volume":"69","author":"N Wald-Dickler","year":"2019","unstructured":"Wald-Dickler N, Spellberg B (2019) Short-course antibiotic therapy-replacing constantine units with \u201cshorter is better.\u201d Clin Infect Dis 69:1476\u20131479","journal-title":"Clin Infect Dis"},{"key":"8063_CR126","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","volume":"392","author":"N Daneman","year":"2025","unstructured":"Daneman N, Rishu A, Pinto R, Rogers BA, Shehabi Y, Parke R, Cook D, Arabi Y, Muscedere J, Reynolds S, Hall R, Dwivedi DB, McArthur C, McGuinness S, Yahav D, Coburn B, Geagea A, Das P, Shin P, Detsky M, Morris A, Fralick M, Powis JE, Kandel C, Sligl W, Bagshaw SM, Singhal N, Belley-Cote E, Whitlock R, Khwaja K, Morpeth S, Kazemi A, Williams A, MacFadden DR, McIntyre L, Tsang J, Lamontagne F, Carignan A, Marshall J, Friedrich JO, Cirone R, Downing M, Graham C, Davis J, Duan E, Neary J, Evans G, Alraddadi B, Al Johani S, Martin C, Elsayed S, Ball I, Lauzier F, Turgeon A, Stelfox HT, Conly J, McDonald EG, Lee TC, Sullivan R, Grant J, Kagan I, Young P, Lawrence C, O\u2019Callaghan K, Eustace M, Choong K, Aslanian P, Buehner U, Havey T, Binnie A, Prazak J, Reeve B, Litton E, Lother S, Kumar A, Zarychanski R, Hoffman T, Paterson D, Daley P, Commons RJ, Charbonney E, Naud JF, Roberts S, Tiruvoipati R, Gupta S, Wood G, Shum O, Miyakis S, Dodek P, Kwok C, Fowler RA, Balance Investigators ftCCCTGtAoMM, Infectious Disease Canada Clinical Research Network tA, New Zealand Intensive Care Society Clinical Trials G, the Australasian Society for Infectious Diseases Clinical Research N (2025) Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections. N Engl J Med 392:1065\u20131078","journal-title":"N Engl J Med"},{"key":"8063_CR127","doi-asserted-by":"publisher","first-page":"ofac706","DOI":"10.1093\/ofid\/ofac706","volume":"10","author":"K Davar","year":"2023","unstructured":"Davar K, Clark D, Centor RM, Dominguez F, Ghanem B, Lee R, Lee TC, McDonald EG, Phillips MC, Sendi P, Spellberg B (2023) Can the future of ID escape the inertial dogma of its past? The exemplars of shorter is better and oral is the new IV. Open Forum Infect Dis 10:ofac706","journal-title":"Open Forum Infect Dis"},{"key":"8063_CR128","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00134-025-07857-6","volume":"51","author":"L Gajdos","year":"2025","unstructured":"Gajdos L, Buetti N, Tabah A, Ruckly S, Akova M, Sjoval F, Arvanti K, de Waele J, Bracht H, Barbier F, Timsit JF, Eurobact-2, ESICM, ESCMID, ESGCIP, OUTCOMEREA (2025) Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database. Intensive Care Med 51:518\u2013528","journal-title":"Intensive Care Med"},{"key":"8063_CR129","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S, Pneum ATG (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588\u20132598","journal-title":"JAMA"},{"key":"8063_CR130","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00134-018-5088-x","volume":"44","author":"P Montravers","year":"2018","unstructured":"Montravers P, Tubach F, Lescot T, Veber B, Esposito-Farese M, Seguin P, Paugam C, Lepape A, Meistelman C, Cousson J, Tesniere A, Plantefeve G, Blasco G, Asehnoune K, Jaber S, Lasocki S, Dupont H, Group DT (2018) Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med 44:300\u2013310","journal-title":"Intensive Care Med"},{"key":"8063_CR131","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","volume":"372","author":"RG Sawyer","year":"2015","unstructured":"Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, Cook CH, O\u2019Neill PJ, Mazuski JE, Askari R, Wilson MA, Napolitano LM, Namias N, Miller PR, Dellinger EP, Watson CM, Coimbra R, Dent DL, Lowry SF, Cocanour CS, West MA, Banton KL, Cheadle WG, Lipsett PA, Guidry CA, Popovsky K, Investigators S-IT (2015) Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 372:1996\u20132005","journal-title":"N Engl J Med"},{"key":"8063_CR132","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/bmjqs-2020-012479","volume":"31","author":"AM Pandolfo","year":"2022","unstructured":"Pandolfo AM, Horne R, Jani Y, Reader TW, Bidad N, Brealey D, Enne VI, Livermore DM, Gant V, Brett SJ, Group IWS (2022) Understanding decisions about antibiotic prescribing in ICU: an application of the Necessity Concerns Framework. BMJ Qual Saf 31:199\u2013210","journal-title":"BMJ Qual Saf"},{"key":"8063_CR133","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1089\/sur.2006.7.419","volume":"7","author":"TL Hedrick","year":"2006","unstructured":"Hedrick TL, Evans HL, Smith RL, McElearney ST, Schulman AS, Chong TW, Pruett TL, Sawyer RG (2006) Can we define the ideal duration of antibiotic therapy? Surg Infect (Larchmt) 7:419\u2013432","journal-title":"Surg Infect (Larchmt)"},{"key":"8063_CR134","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jama.2024.26458","volume":"333","author":"P Dark","year":"2025","unstructured":"Dark P, Hossain A, McAuley DF, Brealey D, Carlson G, Clayton JC, Felton TW, Ghuman BK, Gordon AC, Hellyer TP, Lone NI, Manazar U, Richards G, McCullagh IJ, McMullan R, McNamee JJ, McNeil HC, Mouncey PR, Naisbitt MJ, Parker RJ, Poole RL, Rostron AJ, Singer M, Stevenson MD, Walsh TS, Welters ID, Whitehouse T, Whiteley S, Wilson P, Young KK, Perkins GD, Lall R, Collaborators AD-S (2025) Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-sepsis randomized clinical trial. JAMA 333:682\u2013693","journal-title":"JAMA"},{"key":"8063_CR135","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s13054-023-04677-2","volume":"27","author":"M Papp","year":"2023","unstructured":"Papp M, Kiss N, Baka M, Trasy D, Zubek L, Fehervari P, Harnos A, Turan C, Hegyi P, Molnar Z (2023) Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis. Crit Care 27:394","journal-title":"Crit Care"},{"key":"8063_CR136","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00134-019-05846-0","volume":"46","author":"J Schouten","year":"2020","unstructured":"Schouten J, De Angelis G, De Waele JJ (2020) A microbiologist consultant should attend daily ICU rounds. Intensive Care Med 46:372\u2013374","journal-title":"Intensive Care Med"},{"key":"8063_CR137","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","volume":"20","author":"CY Chiu","year":"2019","unstructured":"Chiu CY, Miller SA (2019) Clinical metagenomics. Nat Rev Genet 20:341\u2013355","journal-title":"Nat Rev Genet"},{"key":"8063_CR138","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178003","volume":"134","author":"KG Rodino","year":"2024","unstructured":"Rodino KG, Simner PJ (2024) Status check: next-generation sequencing for infectious-disease diagnostics. J Clin Invest 134:e178003","journal-title":"J Clin Invest"},{"key":"8063_CR139","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00526-22","volume":"60","author":"DC Gaston","year":"2022","unstructured":"Gaston DC, Miller HB, Fissel JA, Jacobs E, Gough E, Wu J, Klein EY, Carroll KC, Simner PJ (2022) Evaluation of metagenomic and targeted next-generation sequencing workflows for detection of respiratory pathogens from bronchoalveolar lavage fluid specimens. J Clin Microbiol 60:e0052622","journal-title":"J Clin Microbiol"},{"key":"8063_CR140","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00134-015-4188-0","volume":"42","author":"MH Abdul-Aziz","year":"2016","unstructured":"Abdul-Aziz MH, Sulaiman H, Mat-Nor MB, Rai V, Wong KK, Hasan MS, Abd Rahman AN, Jamal JA, Wallis SC, Lipman J, Staatz CE, Roberts JA (2016) Beta-lactam infusion in severe sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. Intensive Care Med 42:1535\u20131545","journal-title":"Intensive Care Med"},{"key":"8063_CR141","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/cpt.2182","volume":"109","author":"LE Friberg","year":"2021","unstructured":"Friberg LE (2021) Pivotal role of translation in anti-infective development. Clin Pharmacol Ther 109:856\u2013866","journal-title":"Clin Pharmacol Ther"},{"key":"8063_CR142","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01587-19","volume":"64","author":"M Hussein","year":"2019","unstructured":"Hussein M, Han ML, Zhu Y, Zhou Q, Lin YW, Hancock REW, Hoyer D, Creek DJ, Li J, Velkov T (2019) Metabolomics study of the synergistic killing of polymyxin B in combination with amikacin against polymyxin-susceptible and -resistant pseudomonas aeruginosa. Antimicrob Agents Chemother 64:e01587","journal-title":"Antimicrob Agents Chemother"},{"key":"8063_CR143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006726","volume":"14","author":"U Sela","year":"2018","unstructured":"Sela U, Euler CW, Correa da Rosa J, Fischetti VA (2018) Strains of bacterial species induce a greatly varied acute adaptive immune response: The contribution of the accessory genome. PLoS Pathog 14:e1006726","journal-title":"PLoS Pathog"},{"key":"8063_CR144","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ (2021) The immunology of sepsis. Immunity 54:2450\u20132464","journal-title":"Immunity"},{"key":"8063_CR145","doi-asserted-by":"publisher","first-page":"e795","DOI":"10.1016\/S2666-5247(22)00121-5","volume":"3","author":"ZP Bulman","year":"2022","unstructured":"Bulman ZP, Wicha SG, Nielsen EI, Lenhard JR, Nation RL, Theuretzbacher U, Derendorf H, Tangden T, Zeitlinger M, Landersdorfer CB, Bulitta JB, Friberg LE, Li J, Tsuji BT, International Society of Anti-Infective P, European Society of Clinical M, Infectious Diseases P, Pharmacodynamics of Anti-Infectives Study G, International Society of Antimicrobial Chemotherapy Anti-Infective Pharmacology Working G (2022) Research priorities towards precision antibiotic therapy to improve patient care. Lancet Microbe 3:e795\u2013e802","journal-title":"Lancet Microbe"},{"key":"8063_CR146","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s00134-025-07873-6","volume":"51","author":"DB Antcliffe","year":"2025","unstructured":"Antcliffe DB, Burrell A, Boyle AJ, Gordon AC, McAuley DF, Silversides J (2025) Sepsis subphenotypes, theragnostics and personalized sepsis care. Intensive Care Med 51:756\u2013768","journal-title":"Intensive Care Med"},{"key":"8063_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.iccn.2022.103227","volume":"70","author":"S Blot","year":"2022","unstructured":"Blot S, Ruppe E, Harbarth S, Asehnoune K, Poulakou G, Luyt CE, Rello J, Klompas M, Depuydt P, Eckmann C, Martin-Loeches I, Povoa P, Bouadma L, Timsit JF, Zahar JR (2022) Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs 70:103227","journal-title":"Intensive Crit Care Nurs"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08063-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-025-08063-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08063-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:10:43Z","timestamp":1779797443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-025-08063-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":147,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["8063"],"URL":"https:\/\/doi.org\/10.1007\/s00134-025-08063-0","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare the following financial interests\/personal relationships, which may be considered as potential competing interests. J-FT; received research grants from Pfizer, Merck, was speaker in conferences for Pfizer, Advanz, Biomerieux, Shionogi, Mundipharma, Qiagen, and participates to advisory boards organised by Menarini, Biomerieux, Merck, Advanz pharma all out of the submitted article. LL Non-financial research support from Biomerieux; received funding from Health and Medical Research Fund of the Health Bureau of Hong Kong SAR Government (No. 18190381) to support this work. EdM none; HB none; ACM speaking fees Biomerieux, Thermo-Fisher, Fischer and Paykel and Boston Scientific (paid to institution); ACM is supported by a Clinician Scientist Fellowship from the UK Medical Research Council (MR\/V006118\/1); LdB none; MF received research\u00a0grants from Gilead and ViiV, and was speaker for conferences\u00a0or advisory boards organised by Pfizer, Menarini, Infectiopharm, Thermo-Fisher; PNAH received research grants from Tamrisa, Microbio and Gilead, honoraria for speaking events from Pfizer, Biomerieux and Gilead and has served on advisory boards for Sandoz and OpGen and received travel support from Shionogi; FRM none; J-AP Talks or advisory boards for Pfizer, Merck-Sharp-Dohme, Gilead, AOP Orphan Pharmaceuticals, Cepheid; DLP received research funding from Shionogi, Merck, bioM\u00e9rieux, BioVersys, Gilead and Pfizer, consulting fees from the AMR Action Fund, CARB-X, GARDP, Aurobac, Pfizer, Merck, Cepheid, bioM\u00e9rieux, and Spero.; GP Grants\/Research Support:Pfizer, MSD, Gilead,\u00a0Menarini,\u00a0PharmaMar,\u00a0Fabentech, Bausch, Astra-Zeneca, Hellenic Institute for the Study of Sepsis, University College London\/University of Minnesota; Scientific Advisory board:\u00a0Pfizer, Astra-Zeneca, Gilead, MSD, Menarini, SOBI; CR received speaker\u2019s fees from Shionogi, bioMerieux, AOP Orphan, Advanz Pharma, Fresenius, Pfizer and MSD. attended Scientific Advisory Board from bioMerieux, Advanz Pharma and Viatris; JAR Consultancies\/Advisory Boards\u2014Sandoz (2024); Wolters Kluwer (2024); Qpex (2022); Gilead (2022); Advanz Pharma (2022); Speaking Fees\u2014Sandoz (2024); Pfizer (2023); MSD (2022); Gilead (2022); Industry Grants\u2014Biomerieux (2024); Pfizer (2023); AFS Consultant to Merck, Pfizer and Eagle Pharmaceuticals; AT none; JL none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}